Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Urolithin A improves muscle function; Amazentis conducts clinical trial

July 14, 2016

Biocad's bispecific MAb shows promise for rheumatoid arthritis in preclinical studies

July 13, 2016

FDA confers orphan drug status to angiogenesis inhibitor nintedanib

July 12, 2016

Positive topline results from phase IIb trial of vobarilizumab as monotherapy in RA

July 8, 2016

FDA grants orphan drug designation for iBio-CFB03

July 7, 2016

Roche and Genentech report retinoid RORgamma ligands

July 6, 2016

Simponi receives approval in Europe for treatment of polyarticular juvenile idiopathic arthritis

July 5, 2016

Pimco 2664 presents compounds for rheumatoid arthritis

July 5, 2016

Ampio announces results from phase III PIVOT clinical trial

July 1, 2016

IL-22 linked to aberrant bone formation in spondyloarthropathies

June 28, 2016

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...